Found: 49
Select item for more details and to access through your institution.
Learning from our patients: one participant's impact on clinical trial research and informed consent.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Evaluating the activity of temsirolimus in neuroendocrine cancer.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
- Published in:
- British Journal of Cancer, 2006, v. 95, n. 5, p. 581, doi. 10.1038/sj.bjc.6603291
- By:
- Publication type:
- Article
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 49, doi. 10.1038/tpj.2008.13
- By:
- Publication type:
- Article
Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 2, p. 152, doi. 10.1038/sj.tpj.6500454
- By:
- Publication type:
- Article
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 43, doi. 10.1038/sj.tpj.6500072
- By:
- Publication type:
- Article
Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
- Published in:
- 1999
- By:
- Publication type:
- journal article
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precision.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
- Published in:
- Clinical & Experimental Dermatology, 2006, v. 31, n. 6, p. 783, doi. 10.1111/j.1365-2230.2006.02223.x
- By:
- Publication type:
- Article
Pharmacogenetics: a tool for individualizing antineoplastic therapy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Mineralocorticoid insufficiency due to suramin therapy.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Prognostic factors for survival in patients treated in phase I clinical trials.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase I study of intermittent infusion cladribine in patients with solid tumors.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 6, p. 564, doi. 10.1038/tpj.2014.27
- By:
- Publication type:
- Article
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 4, p. 336, doi. 10.1038/tpj.2014.2
- By:
- Publication type:
- Article
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 5, p. 396, doi. 10.1038/tpj.2012.20
- By:
- Publication type:
- Article
Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 5, p. 369, doi. 10.1093/jnci/80.5.369
- By:
- Publication type:
- Article
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Evaluation of neuropathy in patients on suramin treatment.
- Published in:
- 1997
- By:
- Publication type:
- journal article
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Meaningful Use of Pharmacogenetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 6, p. 650, doi. 10.1038/clpt.2014.188
- By:
- Publication type:
- Article
Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 1, p. 27, doi. 10.1038/clpt.2014.63
- By:
- Publication type:
- Article
Conventional Dosing of Anticancer Agents: Precisely Wrong or Just Inaccurate?
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 361, doi. 10.1038/clpt.2014.12
- By:
- Publication type:
- Article
Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 6, p. 631, doi. 10.1038/clpt.2013.178
- By:
- Publication type:
- Article
Are Drug Labels Static or Dynamic?
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 3, p. 302, doi. 10.1038/clpt.2013.109
- By:
- Publication type:
- Article
CYP2D6 Genotype and Tamoxifen Activity: Understanding Interstudy Variability in Methodological Quality.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 185, doi. 10.1038/clpt.2013.66
- By:
- Publication type:
- Article
Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 4, p. 345, doi. 10.1038/clpt.2012.263
- By:
- Publication type:
- Article
Playing Russian Roulette With Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 3, p. 242, doi. 10.1038/clpt.2012.245
- By:
- Publication type:
- Article
Models of Excellence: Improving Oncology Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 548, doi. 10.1038/clpt.2012.99
- By:
- Publication type:
- Article
The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 4, p. 446, doi. 10.1038/clpt.2012.117
- By:
- Publication type:
- Article
Merrill Jon Egorin, MD, 1948-2010.
- Published in:
- 2011
- By:
- Publication type:
- Obituary
A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 87, n. 3, p. 303, doi. 10.1038/clpt.2009.217
- By:
- Publication type:
- Article
Biomarkers in Early Cancer Drug Development: Limited Utility.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 134, doi. 10.1038/clpt.2008.231
- By:
- Publication type:
- Article
Pharmacogenetic Pathway Analysis of Irinotecan.
- Published in:
- Clinical Pharmacology & Therapeutics, 2008, v. 84, n. 3, p. 393, doi. 10.1038/clpt.2008.63
- By:
- Publication type:
- Article
Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 82, n. 4, p. 381, doi. 10.1038/sj.clpt.6100317
- By:
- Publication type:
- Article
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 3, p. 328, doi. 10.1038/sj.clpt.6100087
- By:
- Publication type:
- Article
Personalized Medicine: Building the GPS to Take Us There.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Green tea and irinotecan metabolism.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P36, doi. 10.1016/j.clpt.2003.11.136
- By:
- Publication type:
- Article
Role of CYP3A4 and CYP2B6 in the in vitro N-demethylation of meperidine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P85, doi. 10.1016/j.clpt.2003.11.325
- By:
- Publication type:
- Article
In vitro glucuronidation of ABT-751, a novel anticancer agent.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P86, doi. 10.1016/j.clpt.2003.11.328
- By:
- Publication type:
- Article
Pharmacogenetics of flavopiridol, glucuronidation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P60, doi. 10.1016/S0009-9236(03)90577-7
- By:
- Publication type:
- Article
Use of CPT-11 as an in vitro phenotypic probe for CYP3A4/CYP3A5 activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P61, doi. 10.1016/S0009-9236(03)90582-0
- By:
- Publication type:
- Article